Significant miRNAs as Potential Biomarkers to Differentiate Moyamoya Disease From Intracranial Atherosclerotic Disease
- PMID: 40065456
- PMCID: PMC11896741
- DOI: 10.3988/jcn.2024.0351
Significant miRNAs as Potential Biomarkers to Differentiate Moyamoya Disease From Intracranial Atherosclerotic Disease
Conflict of interest statement
Hyuk Sung Kwon and Seong-Ho Koh, a contributing editors of the Journal of Clinical Neurology, were not involved in the editorial evaluation or decision to publish this article. All remaining authors have declared no conflicts of interest.
References
-
- Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, et al. Moyamoya disease: diagnosis and interventions. Lancet Neurol. 2022;21:747–758. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources